6400 RESULTS
Sort By:
More news updates from the 8th International Conference on Alzheimer’s Disease and Related Disorders in Stockholm: In a wide-ranging and eloquent presentation, Christian Haass provided several experimental proofs that a small amount of presenilin is detected at the plasma membrane...
Ever since Cao and Sudhof provided the first evidence that the intracellular domain of APP (AICD) translocates to the nucleus and may be involved in transcriptional regulation, there has been a reawakening of interest in APP function...
Over the past decade, new technologies have led to an explosion in the generation of biological data, leaving scientists wishing for a simple way to assimilate and then present the new information...
Researchers from Israel presented information about a highly potent peptide that, in rodents, shows promise as a future neuroprotective treatment.
The latest clinical trial of two non-steriodal anti-inflammatory drugs has shown no efficacy.
The Aβ peptide that circulates in the periphery is degraded not primarily by the kidney, but in the liver, scientists report at the 8th International Conference on Alzheimer’s Disease and Related Disorders in Stockholm.
Researchers in several labs are trying to discover the genes whose expression might be controlled by the C-terminal fragment of APP. The answer is not yet in, but read about some clues presented at the 8th International Conference on Alzheimer’s Disease and Related Disorders...
Is α-T catenin the elusive LOAD gene on chromosome 10? Or is it one of several genes? Read about Steve Younkin et al.'s presentation at the 8th International Conference on Alzheimer’s Disease and Related Disorders in Stockholm...
Course Correction on NSAIDs: Reanalysis of Rotterdam data suggest only those NSAIDs that appear to affect AβPP processing protect against AD.
Coverage by Keith Crutcher from the Genetics Symposium at the 8th International Conference on Alzheimer’s Disease and Related Disorders in Stockholm.
More epidemiological data is being reported at the 8th International Conference on Alzheimer’s Disease and Related Disorders in Stockholm to strengthen the association between statin use and lower risk for AD.
Tony Wyss-Coray and colleagues are reporting that disabling the complement cascade, known for its role in innate immunity, causes hippocampal neurodegeneration and exacerbates amyloid deposition. Could this be a way in which microglial activation is beneficial in AD?
Are two new proteins the missing links to understand the γ-secretase complex? Research presented today at the 8th International Conference on Alzheimer’s Disease and Related Disorders in Stockholm suggests as much. Are more components yet to be discovered?
Can coronary artery bypass surgery cause long-term cognitive deficits? New imaging study fuels debate.
Today at the 8th International Conference on Alzheimer’s Disease and Related Disorders, David Holtzman's group reports that the lipid-binding protein ApoJ modulates the formation of amyloid deposits and neuritic toxicity in vivo.
